BMW Advancing Fuel Cell Vehicle Trials

France Nouvelles Nouvelles

BMW Advancing Fuel Cell Vehicle Trials
France Dernières Nouvelles,France Actualités
  • 📰 cleantechnica
  • ⏱ Reading Time:
  • 62 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 51%

BMW continues down the road the path of fuel cell powered passenger cars as part of its corporate strategy for the future.

, Hyundai, and BMW are hard at work perfecting hydrogen fuel cells for light duty passenger cars. We all know by now that hydrogen fuel cells create no harmful waste products. In operation, they produce electricity, water, and heat. That’s it. So in a fuel cell powered world, there would be no climate killing emissions at all — just like there are none with battery electric cars.

Older readers may remember when diesel-powered passenger cars were all the rage in America in the 80s. Back then, motorists with diesel engines under the hood had to go to truck stops to buy fuel for their cars. Apparently Zipse and BMW see a similar situation coming for fuel cell powered cars.

Last August, the BMW factory in South Carolina produced a fleet of 100 iX5 SUVs that were then shipped to Germany to be outfitted with fuel cell systems. They are being used in a two-year-long test of the technology in Europe, the US, and Asia. Zipse sees hydrogen cars as the preferred option for drivers frequently making longer journeys who struggle with patchy charging infrastructure for battery-electric cars.

. In it, she quoted Frank Weber, BMW’s head of development, as saying, “We are certain that hydrogen is set to gain significantly in importance for individual mobility and therefore consider a mixture of battery and fuel cell electric drive systems to be a sensible approach in the long term. Our BMW iX5 Hydrogen test fleet will allow us to gain new and valuable insights, enabling us to present customers with an attractive product range once the hydrogen economy becomes a widespread reality.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

cleantechnica /  🏆 565. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Honda Doubles Down On Fuel Cell Electric Car CommitmentHonda Doubles Down On Fuel Cell Electric Car CommitmentHonda and GM have a message for fuel cell electric car fans: never give up, never surrender, and keep an eye out for a mashup with batteries.
Lire la suite »

Plans for new pediatric campus are advancing, UT Southwestern president saysPlans for new pediatric campus are advancing, UT Southwestern president saysUT Southwestern is planning to construct a new pediatric hospital campus where the Bass Center buildings are currently located on the medical center’s campus,...
Lire la suite »

The New BMW X7 M60i Can't Compete With A Lamborghini Urus - Or Can It? | CarscoopsThe New BMW X7 M60i Can't Compete With A Lamborghini Urus - Or Can It? | CarscoopsThe New BMW X7 M60i Can't Compete With A Lamborghini Urus - Or Can It? | Carscoops carscoops
Lire la suite »

Beyond the Mythical “Average” Cell – A New Framework for Understanding BacteriaBeyond the Mythical “Average” Cell – A New Framework for Understanding BacteriaMolecular biologists aim to understand the actual events within individual living cells, not just the behavior of the mythical 'average' cell. No one aspires to be average. However, for a long time, scientists have found it convenient to consider bacterial cells as merely 'average.' Historically
Lire la suite »

New CAR T-Cell Immunotherapy Holds Promise for Ovarian Cancer PatientsNew CAR T-Cell Immunotherapy Holds Promise for Ovarian Cancer PatientsCAR T-cell therapy, a certain kind of cancer treatment in which the immune system’s T cells are programmed to attack tumor cells, is effective in mice with ovarian cancer, according to a study published in The Journal for ImmunoTherapy of Cancer. The researchers, who work at Karolinska Institutet, h
Lire la suite »

Early-Stage Resectable Non-Small Cell Lung Cancer: Navigating a Changing Treatment LandscapeEarly-Stage Resectable Non-Small Cell Lung Cancer: Navigating a Changing Treatment Landscape🖥️ Did you know that there are now promising perioperative immunotherapies available for your patients with early-stage NSCLC? CME MedEd MedTwitter 📝
Lire la suite »



Render Time: 2025-03-03 00:20:40